Structured Review

Eppendorf AG eppendorf 5417r
Eppendorf 5417r, supplied by Eppendorf AG, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/eppendorf 5417r/product/Eppendorf AG
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
eppendorf 5417r - by Bioz Stars, 2021-09
86/100 stars

Images

Related Articles

Sequencing:

Article Title: Loss of the disease-associated glycosyltransferase Galnt3 alters Muc10 glycosylation and the composition of the oral microbiome
Article Snippet: .. 16S rRNA gene-based sequencing and bioinformatic analysesLibrary generation was performed using Eppendorf liquid-handling robots. ..

Similar Products

  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86
    Eppendorf AG serial benchtop centrifugation
    Patients with unstable CAD have a decreased concentration of uEVs. EVs were isolated from 6 ml of urine using a <t>benchtop</t> centrifugation protocol. (A) Images of uEVs were taken using an FEI Tecnai 12 Transmission Electron Microscope (Magnification: 43,000× and 135,000×). (B) The total concentration of particles (5-200nm) was determined by NTA using the NanoSight NS300. (C) R Studio analysis was performed to compare the size distribution and concentration of the NTA data. (D) The EV (Bodipy + ) concentration was determined by flow cytometry using the ImageStream™X Mark II. (E) The percentage of CD63 + Bodipy + EVs was also determined. (F) Images of EVs stained with Bodipy and positive for the fluorescent antibodies CD63 and CD45 were obtained using the ImageStream™X Flow Cytometer. Statistical analysis was performed using nonparametric Mann Whitney U tests where *p
    Serial Benchtop Centrifugation, supplied by Eppendorf AG, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/serial benchtop centrifugation/product/Eppendorf AG
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    serial benchtop centrifugation - by Bioz Stars, 2021-09
    86/100 stars
      Buy from Supplier

    93
    Eppendorf AG nanoemulsion centrifugation
    <t>Nanoemulsion</t> droplet size evaluated during storage for ClFPh-CHA-loaded (gray bars) and blank nanoemulsions (white bars).
    Nanoemulsion Centrifugation, supplied by Eppendorf AG, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nanoemulsion centrifugation/product/Eppendorf AG
    Average 93 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    nanoemulsion centrifugation - by Bioz Stars, 2021-09
    93/100 stars
      Buy from Supplier

    86
    Eppendorf AG eppendorf 5417r
    <t>Nanoemulsion</t> droplet size evaluated during storage for ClFPh-CHA-loaded (gray bars) and blank nanoemulsions (white bars).
    Eppendorf 5417r, supplied by Eppendorf AG, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/eppendorf 5417r/product/Eppendorf AG
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    eppendorf 5417r - by Bioz Stars, 2021-09
    86/100 stars
      Buy from Supplier

    Image Search Results


    Patients with unstable CAD have a decreased concentration of uEVs. EVs were isolated from 6 ml of urine using a benchtop centrifugation protocol. (A) Images of uEVs were taken using an FEI Tecnai 12 Transmission Electron Microscope (Magnification: 43,000× and 135,000×). (B) The total concentration of particles (5-200nm) was determined by NTA using the NanoSight NS300. (C) R Studio analysis was performed to compare the size distribution and concentration of the NTA data. (D) The EV (Bodipy + ) concentration was determined by flow cytometry using the ImageStream™X Mark II. (E) The percentage of CD63 + Bodipy + EVs was also determined. (F) Images of EVs stained with Bodipy and positive for the fluorescent antibodies CD63 and CD45 were obtained using the ImageStream™X Flow Cytometer. Statistical analysis was performed using nonparametric Mann Whitney U tests where *p

    Journal: Frontiers in Immunology

    Article Title: microRNA-155 Is Decreased During Atherosclerosis Regression and Is Increased in Urinary Extracellular Vesicles During Atherosclerosis Progression

    doi: 10.3389/fimmu.2020.576516

    Figure Lengend Snippet: Patients with unstable CAD have a decreased concentration of uEVs. EVs were isolated from 6 ml of urine using a benchtop centrifugation protocol. (A) Images of uEVs were taken using an FEI Tecnai 12 Transmission Electron Microscope (Magnification: 43,000× and 135,000×). (B) The total concentration of particles (5-200nm) was determined by NTA using the NanoSight NS300. (C) R Studio analysis was performed to compare the size distribution and concentration of the NTA data. (D) The EV (Bodipy + ) concentration was determined by flow cytometry using the ImageStream™X Mark II. (E) The percentage of CD63 + Bodipy + EVs was also determined. (F) Images of EVs stained with Bodipy and positive for the fluorescent antibodies CD63 and CD45 were obtained using the ImageStream™X Flow Cytometer. Statistical analysis was performed using nonparametric Mann Whitney U tests where *p

    Article Snippet: Urinary Extracellular Vesicle Isolation and Characterization EVs were isolated from urine via serial benchtop centrifugation (Eppendorf Centrifuge 5417R) at 4°C.

    Techniques: Concentration Assay, Isolation, Centrifugation, Transmission Assay, Microscopy, Flow Cytometry, Staining, MANN-WHITNEY

    Nanoemulsion droplet size evaluated during storage for ClFPh-CHA-loaded (gray bars) and blank nanoemulsions (white bars).

    Journal: Nanomaterials

    Article Title: Nanoemulsion-Enabled Oral Delivery of Novel Anticancer ω-3 Fatty Acid Derivatives

    doi: 10.3390/nano8100825

    Figure Lengend Snippet: Nanoemulsion droplet size evaluated during storage for ClFPh-CHA-loaded (gray bars) and blank nanoemulsions (white bars).

    Article Snippet: Characterization of samples in terms of preparation particle size distribution (z -average and PDI) was conducted at predetermined intervals after their preparation and compared with the initial values. (d) Determination of Encapsulation Efficiency The encapsulation efficiency (EE%) of compound ClFPh-CHA into nanoemulsion was determined indirectly by the ultrafiltration method according to Equation (1). (1) EE % = ( NE Total − NE Aqueous ) NE E Total × 100 , The percentage of encapsulated substance was calculated as the difference between the total amount of compound in the formulation, which was measured after the dissolution of the nanoemulsion in methanol (NE Total), and the amount of compound present in the aqueous phase (NE Aqueous) calculated from its concentration measured in the aqueous ultrafiltrate obtained from the nanoemulsion centrifugation (5 min, 2700× g , Centrifuge 5417R, Eppendorf, Macquarie Park, NSW, Australia) using centrifugal filter tubes (Ultrafree® CL, cut-off 10,000 MW, Millipore, Burlington, MA, USA), divided by the total amount of compound in the nanoemulsion (NE Total) multiplied by 100.

    Techniques:

    Dose-dependent effects of ClFPh-CHA on the in vivo growth of MDA-MB-231 cell xenografts. ClFPh-CHA was delivered orally as a nanoemulsion ( a ) or by intraperitoneal injection as a solution ( b ). Control groups in each experiment received vehicle only. Different from control: *** P

    Journal: Nanomaterials

    Article Title: Nanoemulsion-Enabled Oral Delivery of Novel Anticancer ω-3 Fatty Acid Derivatives

    doi: 10.3390/nano8100825

    Figure Lengend Snippet: Dose-dependent effects of ClFPh-CHA on the in vivo growth of MDA-MB-231 cell xenografts. ClFPh-CHA was delivered orally as a nanoemulsion ( a ) or by intraperitoneal injection as a solution ( b ). Control groups in each experiment received vehicle only. Different from control: *** P

    Article Snippet: Characterization of samples in terms of preparation particle size distribution (z -average and PDI) was conducted at predetermined intervals after their preparation and compared with the initial values. (d) Determination of Encapsulation Efficiency The encapsulation efficiency (EE%) of compound ClFPh-CHA into nanoemulsion was determined indirectly by the ultrafiltration method according to Equation (1). (1) EE % = ( NE Total − NE Aqueous ) NE E Total × 100 , The percentage of encapsulated substance was calculated as the difference between the total amount of compound in the formulation, which was measured after the dissolution of the nanoemulsion in methanol (NE Total), and the amount of compound present in the aqueous phase (NE Aqueous) calculated from its concentration measured in the aqueous ultrafiltrate obtained from the nanoemulsion centrifugation (5 min, 2700× g , Centrifuge 5417R, Eppendorf, Macquarie Park, NSW, Australia) using centrifugal filter tubes (Ultrafree® CL, cut-off 10,000 MW, Millipore, Burlington, MA, USA), divided by the total amount of compound in the nanoemulsion (NE Total) multiplied by 100.

    Techniques: In Vivo, Multiple Displacement Amplification, Injection

    Final weights of excised tumors were determined at necropsy for ( a ) mice receiving increasing doses of ClFPh-CHA-loaded nanoemulsion orally and ( b ) mice receiving increasing doses of ClFPh-CHA in solution by intraperitoneal injection (32 days and 38 days of daily treatment for oral and IP administration, respectively). Values were compared to tumor weights of control groups of mice that received vehicle only (CTL). Different from control: * P

    Journal: Nanomaterials

    Article Title: Nanoemulsion-Enabled Oral Delivery of Novel Anticancer ω-3 Fatty Acid Derivatives

    doi: 10.3390/nano8100825

    Figure Lengend Snippet: Final weights of excised tumors were determined at necropsy for ( a ) mice receiving increasing doses of ClFPh-CHA-loaded nanoemulsion orally and ( b ) mice receiving increasing doses of ClFPh-CHA in solution by intraperitoneal injection (32 days and 38 days of daily treatment for oral and IP administration, respectively). Values were compared to tumor weights of control groups of mice that received vehicle only (CTL). Different from control: * P

    Article Snippet: Characterization of samples in terms of preparation particle size distribution (z -average and PDI) was conducted at predetermined intervals after their preparation and compared with the initial values. (d) Determination of Encapsulation Efficiency The encapsulation efficiency (EE%) of compound ClFPh-CHA into nanoemulsion was determined indirectly by the ultrafiltration method according to Equation (1). (1) EE % = ( NE Total − NE Aqueous ) NE E Total × 100 , The percentage of encapsulated substance was calculated as the difference between the total amount of compound in the formulation, which was measured after the dissolution of the nanoemulsion in methanol (NE Total), and the amount of compound present in the aqueous phase (NE Aqueous) calculated from its concentration measured in the aqueous ultrafiltrate obtained from the nanoemulsion centrifugation (5 min, 2700× g , Centrifuge 5417R, Eppendorf, Macquarie Park, NSW, Australia) using centrifugal filter tubes (Ultrafree® CL, cut-off 10,000 MW, Millipore, Burlington, MA, USA), divided by the total amount of compound in the nanoemulsion (NE Total) multiplied by 100.

    Techniques: Mouse Assay, Injection, CTL Assay

    Effect of the number of homogenization cycles on nanoemulsion droplet size (empty circles) and PDI (empty squares).

    Journal: Nanomaterials

    Article Title: Nanoemulsion-Enabled Oral Delivery of Novel Anticancer ω-3 Fatty Acid Derivatives

    doi: 10.3390/nano8100825

    Figure Lengend Snippet: Effect of the number of homogenization cycles on nanoemulsion droplet size (empty circles) and PDI (empty squares).

    Article Snippet: Characterization of samples in terms of preparation particle size distribution (z -average and PDI) was conducted at predetermined intervals after their preparation and compared with the initial values. (d) Determination of Encapsulation Efficiency The encapsulation efficiency (EE%) of compound ClFPh-CHA into nanoemulsion was determined indirectly by the ultrafiltration method according to Equation (1). (1) EE % = ( NE Total − NE Aqueous ) NE E Total × 100 , The percentage of encapsulated substance was calculated as the difference between the total amount of compound in the formulation, which was measured after the dissolution of the nanoemulsion in methanol (NE Total), and the amount of compound present in the aqueous phase (NE Aqueous) calculated from its concentration measured in the aqueous ultrafiltrate obtained from the nanoemulsion centrifugation (5 min, 2700× g , Centrifuge 5417R, Eppendorf, Macquarie Park, NSW, Australia) using centrifugal filter tubes (Ultrafree® CL, cut-off 10,000 MW, Millipore, Burlington, MA, USA), divided by the total amount of compound in the nanoemulsion (NE Total) multiplied by 100.

    Techniques: Homogenization

    Final weights of excised tumors were determined at necropsy for ( a ) mice receiving increasing doses of ClFPh-CHA-loaded nanoemulsion orally and ( b ) mice receiving increasing doses of ClFPh-CHA in solution by intraperitoneal injection (32 days and 38 days of daily treatment for oral and IP administration, respectively). Values were compared to tumor weights of control groups of mice that received vehicle only (CTL). Different from control: * P

    Journal: Nanomaterials

    Article Title: Nanoemulsion-Enabled Oral Delivery of Novel Anticancer ω-3 Fatty Acid Derivatives

    doi: 10.3390/nano8100825

    Figure Lengend Snippet: Final weights of excised tumors were determined at necropsy for ( a ) mice receiving increasing doses of ClFPh-CHA-loaded nanoemulsion orally and ( b ) mice receiving increasing doses of ClFPh-CHA in solution by intraperitoneal injection (32 days and 38 days of daily treatment for oral and IP administration, respectively). Values were compared to tumor weights of control groups of mice that received vehicle only (CTL). Different from control: * P

    Article Snippet: EE % = ( NE Total − NE Aqueous ) NE E Total × 100 , (1) The percentage of encapsulated substance was calculated as the difference between the total amount of compound in the formulation, which was measured after the dissolution of the nanoemulsion in methanol (NE Total), and the amount of compound present in the aqueous phase (NE Aqueous) calculated from its concentration measured in the aqueous ultrafiltrate obtained from the nanoemulsion centrifugation (5 min, 2700× g , Centrifuge 5417R, Eppendorf, Macquarie Park, NSW, Australia) using centrifugal filter tubes (Ultrafree® CL, cut-off 10,000 MW, Millipore, Burlington, MA, USA), divided by the total amount of compound in the nanoemulsion (NE Total) multiplied by 100.

    Techniques: Mouse Assay, Injection, CTL Assay

    Effect of the number of homogenization cycles on nanoemulsion droplet size (empty circles) and PDI (empty squares).

    Journal: Nanomaterials

    Article Title: Nanoemulsion-Enabled Oral Delivery of Novel Anticancer ω-3 Fatty Acid Derivatives

    doi: 10.3390/nano8100825

    Figure Lengend Snippet: Effect of the number of homogenization cycles on nanoemulsion droplet size (empty circles) and PDI (empty squares).

    Article Snippet: EE % = ( NE Total − NE Aqueous ) NE E Total × 100 , (1) The percentage of encapsulated substance was calculated as the difference between the total amount of compound in the formulation, which was measured after the dissolution of the nanoemulsion in methanol (NE Total), and the amount of compound present in the aqueous phase (NE Aqueous) calculated from its concentration measured in the aqueous ultrafiltrate obtained from the nanoemulsion centrifugation (5 min, 2700× g , Centrifuge 5417R, Eppendorf, Macquarie Park, NSW, Australia) using centrifugal filter tubes (Ultrafree® CL, cut-off 10,000 MW, Millipore, Burlington, MA, USA), divided by the total amount of compound in the nanoemulsion (NE Total) multiplied by 100.

    Techniques: Homogenization

    Nanoemulsion droplet size evaluated during storage for ClFPh-CHA-loaded (gray bars) and blank nanoemulsions (white bars).

    Journal: Nanomaterials

    Article Title: Nanoemulsion-Enabled Oral Delivery of Novel Anticancer ω-3 Fatty Acid Derivatives

    doi: 10.3390/nano8100825

    Figure Lengend Snippet: Nanoemulsion droplet size evaluated during storage for ClFPh-CHA-loaded (gray bars) and blank nanoemulsions (white bars).

    Article Snippet: EE % = ( NE Total − NE Aqueous ) NE E Total × 100 , (1) The percentage of encapsulated substance was calculated as the difference between the total amount of compound in the formulation, which was measured after the dissolution of the nanoemulsion in methanol (NE Total), and the amount of compound present in the aqueous phase (NE Aqueous) calculated from its concentration measured in the aqueous ultrafiltrate obtained from the nanoemulsion centrifugation (5 min, 2700× g , Centrifuge 5417R, Eppendorf, Macquarie Park, NSW, Australia) using centrifugal filter tubes (Ultrafree® CL, cut-off 10,000 MW, Millipore, Burlington, MA, USA), divided by the total amount of compound in the nanoemulsion (NE Total) multiplied by 100.

    Techniques:

    Dose-dependent effects of ClFPh-CHA on the in vivo growth of MDA-MB-231 cell xenografts. ClFPh-CHA was delivered orally as a nanoemulsion ( a ) or by intraperitoneal injection as a solution ( b ). Control groups in each experiment received vehicle only. Different from control: *** P

    Journal: Nanomaterials

    Article Title: Nanoemulsion-Enabled Oral Delivery of Novel Anticancer ω-3 Fatty Acid Derivatives

    doi: 10.3390/nano8100825

    Figure Lengend Snippet: Dose-dependent effects of ClFPh-CHA on the in vivo growth of MDA-MB-231 cell xenografts. ClFPh-CHA was delivered orally as a nanoemulsion ( a ) or by intraperitoneal injection as a solution ( b ). Control groups in each experiment received vehicle only. Different from control: *** P

    Article Snippet: EE % = ( NE Total − NE Aqueous ) NE E Total × 100 , (1) The percentage of encapsulated substance was calculated as the difference between the total amount of compound in the formulation, which was measured after the dissolution of the nanoemulsion in methanol (NE Total), and the amount of compound present in the aqueous phase (NE Aqueous) calculated from its concentration measured in the aqueous ultrafiltrate obtained from the nanoemulsion centrifugation (5 min, 2700× g , Centrifuge 5417R, Eppendorf, Macquarie Park, NSW, Australia) using centrifugal filter tubes (Ultrafree® CL, cut-off 10,000 MW, Millipore, Burlington, MA, USA), divided by the total amount of compound in the nanoemulsion (NE Total) multiplied by 100.

    Techniques: In Vivo, Multiple Displacement Amplification, Injection